{"id":"CHEMBL104829","canonicalSmiles":"CN(Cc1coc2nc(N)nc(N)c12)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1","inchiKey":"WXINNGCGSCFUCR-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FURO[2,3D]PYRIMIDINE ANTIFOLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02026"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1068","canonicalSmiles":"NC(=O)N1c2ccccc2CC(=O)c2ccccc21","inchiKey":"CTRLABGOLIVAIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXCARBAZEPINE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxcarbazepine","Oxtellar xr","Trileptal"],"synonyms":["GP-47680","KIN-493","Oxcarbazepine","SPN-804"],"crossReferences":{"DailyMed":["oxcarbazepine"],"PubChem":["144204534","170464811","174006287","26719673","26747194","50085868","866068"],"Wikipedia":["Oxcarbazepine"],"drugbank":["DB00776"],"chEBI":["7824"]},"count":10,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0005762","EFO_1001219","EFO_0004216","HP_0000726","EFO_0003015","HP_0001250","EFO_0000311","HP_0000713","EFO_0003885","EFO_0000474","MONDO_0002050","EFO_0000289","EFO_0004263","EFO_0000270","EFO_0005230","EFO_0000692"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for epilepsy and has 9 investigational indications."}
{"id":"CHEMBL110971","canonicalSmiles":"CCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"COHUUYPEYRMWTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL110971","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06931"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160523","canonicalSmiles":"O=P(O)(O)OCCCc1c[nH]c2ccc(F)cc12","inchiKey":"YVYGGBFCYXRNKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160523","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07773"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161789","canonicalSmiles":"O=S(=O)(O)CCCSc1nc2ccccc2s1","inchiKey":"XBNHRNFODJOFRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161789","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03132"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1175","canonicalSmiles":"CNCC[C@H](Oc1cccc2ccccc12)c1cccs1","inchiKey":"ZEUITGRIYCTCEM-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DULOXETINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cymbalta","Duloxetine","LY-248686","LY248686"],"crossReferences":{"DailyMed":["duloxetine%20hydrochloride"],"PubChem":["124893161","26719725","26757978","49681583"],"Wikipedia":["Duloxetine"],"drugbank":["DB00476"],"chEBI":["36795"]},"childChemblIds":["CHEMBL1200328"],"count":30,"approvedIndications":["MONDO_0002050","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["MONDO_0001583","EFO_0005687","EFO_0004262","MONDO_0002009","EFO_0000555","HP_0000726","EFO_0003829","EFO_1001951","EFO_0009562","EFO_1000783","MONDO_0002050","EFO_0002506","HP_0030834","EFO_0003100","EFO_0000712","EFO_0004616","EFO_0003761","HP_0003419","EFO_1000789","EFO_0004701","HP_0008419","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0000400","EFO_0005762","EFO_0003888","HP_0012532","EFO_0003821","EFO_0002508","EFO_0000677","EFO_0001358","HP_0003418","EFO_0010445","EFO_0003843","EFO_0007169","EFO_0003885","HP_0003326","EFO_1001892","EFO_0008623","HP_0030839","HP_0000020","EFO_0004540"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for depressive disorder and unipolar depression and has 28 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1180003","canonicalSmiles":"CCCCCCCCCCCCCC[N+](C)(C)C","inchiKey":"GLFDLEXFOHUASB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETRIMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cetrimide"],"crossReferences":{"PubChem":["29217879"]},"childChemblIds":["CHEMBL325636","CHEMBL113150","CHEMBL109747"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200562","canonicalSmiles":"CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"FZCHYNWYXKICIO-FZNHGJLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE VALERATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hydrocortisone valerate","Westcort"],"synonyms":["Hydrocortisone valerate"],"crossReferences":{"DailyMed":["hydrocortisone%20valerate"],"PubChem":["144204404","170464775","56422095","855996"],"drugbank":["DB14544"],"chEBI":["50865"]},"count":2,"approvedIndications":["EFO_0009552","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0009552","HP_0004798","EFO_0005752"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for eye inflammation and hemorrhoid."}
{"id":"CHEMBL1200644","canonicalSmiles":"CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)[O-])[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)[O-])[C@H]3NS(=O)(=O)[O-])[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](O)[C@H]1NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"XEKSTYNIJLDDAZ-JASSWCPGSA-D","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"FONDAPARINUX SODIUM","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201202","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arixtra","Fondaparinux sodium"],"synonyms":["Fondaparinux sodium","Fondaparinux sodium for assay","Fondaparinux sodium identification","IC-851589","ORG 31540","ORG-31540","SR 90107A","SR-90107A"],"crossReferences":{"DailyMed":["fondaparinux%20sodium"]},"count":6,"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["HP_0001907","HP_0000083","EFO_0003827","EFO_0004286","EFO_0003907","HP_0004936"],"count":6},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200680","canonicalSmiles":"S=[Se]=S","inchiKey":"JNMWHTHYDQTDQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENIUM SULFIDE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exsel","Lenium","Selenium sulfide","Selsun"],"synonyms":["Selenium disulfide","Selenium sulfide"],"crossReferences":{"DailyMed":["selenium%20sulfide"],"Wikipedia":["Selenium_disulfide"],"drugbank":["DB00971"]},"count":18,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and has 18 investigational indications."}
{"id":"CHEMBL1200819","canonicalSmiles":"CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC.Cl","inchiKey":"GDWDBGSWGNEMGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTICAINE HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1093","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Septanest","Septocaine","Ultracaine"],"synonyms":["40 045","Articaine hydrochloride","Carticaine hydrochloride","HOE 045","HOE-045","HOE-40045"],"crossReferences":{"DailyMed":["articaine%20hydrochloride"],"PubChem":["144204160","170464825","56463593"]},"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000649"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL1200875","canonicalSmiles":"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl","inchiKey":"XOEVKNFZUQEERE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVOXATE HYDROCHLORIDE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1493","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flavoxate hydrochloride","Urispas","Urispas 200"],"synonyms":["DW-61","Flavoxate","Flavoxate hydrochloride","NSC-114649"],"crossReferences":{"DailyMed":["flavoxate%20hydrochloride"],"PubChem":["144204088","170466285"],"chEBI":["5089"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1970."}
{"id":"CHEMBL1200996","canonicalSmiles":"CNC(C)(C)Cc1ccccc1.O=S(=O)(O)O","inchiKey":"NZKLHVGUPFNBFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENTERMINE SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201234","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Wyamine Sulfate"],"synonyms":["Mephentermine sodium"],"crossReferences":{"PubChem":["56463047"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201026","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O=S(=O)(O)O","inchiKey":"OVICLFZZVQVVFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBUTEROL SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL714","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Accuneb","Albuterol Sulfate","Proair Hfa","Proventil","Proventil-Hfa","Ventolin","Ventolin Hfa","Ventolin Rotacaps","Volmax","Vospire Er"],"synonyms":["SCH-13949W"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201073","canonicalSmiles":"O=C(O)[C@H](S)[C@H](S)C(=O)O","inchiKey":"ACTRVOBWPAIOHC-XIXRPRMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCIMER","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chemet","DMSA","Dim-Sa","Dimercaptosuccinic Acid"],"synonyms":["DIM-SA","DMS-A","DMSA","RO 1-7977","Succimer"],"crossReferences":{"DailyMed":["succimer"],"Wikipedia":["Dimercaptosuccinic_acid"],"drugbank":["DB00566"],"chEBI":["63623"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 6 investigational indications."}
{"id":"CHEMBL1201099","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O=P(O)(O)O","inchiKey":"JPGKFBXFEQWCAI-CCLYOLAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CODEINE PHOSPHATE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL485","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ambenyl cough syrup","Bepro","Colrex compound","Evacode","Galcodine"],"synonyms":["Codeine phosphate","Codeine phosphate cii","Codeine phosphate hemihydrate","Codeine phosphate hydrate","Methylmorphine"],"crossReferences":{"DailyMed":["codeine%20phosphate"]},"count":4,"approvedIndications":["EFO_0003821","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0010282","HP_0012735","EFO_0003821","EFO_0000764","HP_0000175","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and is indicated for pain and migraine disorder and has 2 investigational indications."}
{"id":"CHEMBL1201132","canonicalSmiles":"Cl.Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314","inchiKey":"YZLZPSJXMWGIFH-BCXQGASESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NALBUPHINE HYDROCHLORIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL895","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nalbuphine","Nalbuphine hydrochloride","Nubain"],"synonyms":["EN-2234A","Nalbuphine hydrochloride"],"crossReferences":{"DailyMed":["nalbuphine%20hydrochloride"],"PubChem":["56463337"],"chEBI":["7455"]},"count":7,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["MONDO_0026045","HP_0000989","EFO_0005323","EFO_0001421","EFO_0000222","EFO_0005611","EFO_0009267","EFO_0003843","EFO_1001250"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for pain and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201153","canonicalSmiles":"CCC(NC(C)C)C(O)c1ccc(O)c(O)c1.CS(=O)(=O)O","inchiKey":"SOYAGMVKMXZVNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOETHARINE MESYLATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201213","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bronchilator","Bronkometer","Isoetharine mesylate"],"synonyms":["Isoetharine mesylate"],"crossReferences":{"PubChem":["144204319","50106482","56422893","85231307","856022"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984."}
{"id":"CHEMBL1201244","canonicalSmiles":"C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1","inchiKey":"YXRDKMPIGHSVRX-OOJCLDBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCURONIUM","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Rocuronium"],"crossReferences":{"DailyMed":["rocuronium%20bromide"],"PubChem":["50112687"],"Wikipedia":["Rocuronium_bromide"],"drugbank":["DB00728"],"chEBI":["8884"]},"childChemblIds":["CHEMBL1200648"],"count":7,"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["MONDO_0018373","EFO_0003086","MONDO_0021117","EFO_1000637","EFO_0002950","EFO_0003964","MONDO_0001187","EFO_1000218","EFO_0002506","EFO_0010581","EFO_1001250","EFO_0002618","EFO_0001074","HP_0002093","EFO_0009447","EFO_0003832","EFO_0005323","EFO_0001645","MONDO_0007576","HP_0003418","EFO_0001073","EFO_0003843","MONDO_0008315","EFO_0001422","HP_0003326","HP_0001336","HP_0000023","EFO_0009492","HP_0003470"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 7 investigational indications."}
{"id":"CHEMBL121941","canonicalSmiles":"NC(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1","inchiKey":"RUUOIINPNMNPIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL121941","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08241"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230144","canonicalSmiles":"Cc1ccc2c(c1)c1c(n2C[C@@H](O)CNC2CCCCC2)CCCC1","inchiKey":"AXYFCRIRLKSCRR-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230144","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07061"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231486","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1-c1ccc(Br)s1","inchiKey":"IGUZFFOBAZCVRK-VAOFZXAKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231486","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03804"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233085","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)NP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"UQABYHGXWYXDTK-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOAMINOPHOSPHONIC ACID GUANYLATE ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02082"],"chEBI":["78408"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233322","canonicalSmiles":"Nc1nc2c(c(=O)[nH]1)N=C(CO)CN2","inchiKey":"CQQNNQTXUGLUEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233322","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02119"],"chEBI":["17083"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233940","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cc3ccccc3o2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O","inchiKey":"AOMZDQMIOCTPQP-QHQMVRJISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L 756423","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L 756423","L-756423"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1234135","canonicalSmiles":"O=C(O)C(=O)CC(=O)c1cccc(N(Cc2ccccc2)Cc2ccccc2)c1","inchiKey":"RMWVENXKUQXLPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234135","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08147"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123904","canonicalSmiles":"Cc1nc2c(O)cccc2c(=O)[nH]1","inchiKey":"YJDAOHJWLUNFLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NU-1025","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NU-1025"],"crossReferences":{"PubChem":["11114066","525179"],"drugbank":["DB02690"],"chEBI":["75399"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256137","canonicalSmiles":"Cl.NCCS","inchiKey":"OGMADIBCHLQMIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTEAMINE HYDROCHLORIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL602","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cystaran"],"synonyms":["CI-9148","Cysteamine hydrochloride"],"crossReferences":{"DailyMed":["cysteamine%20hydrochloride"],"PubChem":["11533072","144204796","170466795","26747565","50106573","542463"]},"count":1,"approvedIndications":["Orphanet_213"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for cystinosis."}
{"id":"CHEMBL1265","canonicalSmiles":"COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2","inchiKey":"LZCDAPDGXCYOEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADAPALENE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adapalene","Differin"],"synonyms":["Adapalene","CD 271","CD-271","Differin"],"crossReferences":{"DailyMed":["adapalene"],"PubChem":["144205789","170464674","174006867","26758039"],"Wikipedia":["Adapalene"],"drugbank":["DB00210"],"chEBI":["31174"]},"count":2,"approvedIndications":["EFO_0003894"],"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819"],"count":3},"linkedDiseases":{"rows":["MP_0001845","EFO_0000701","EFO_0003894"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for acne and has 1 investigational indication."}
{"id":"CHEMBL1294","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12","inchiKey":"LOUPRKONTZGTKE-LHHVKLHASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINIDINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Quinidine"],"crossReferences":{"DailyMed":["quinidine%20gluconate","quinidine%20sulfate"],"PubChem":["17389531","56320931","56320932"],"drugbank":["DB00908"],"chEBI":["28593"]},"childChemblIds":["CHEMBL2068675","CHEMBL3707183","CHEMBL1435413","CHEMBL1200437","CHEMBL2165709"],"count":13,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0004269","MONDO_0002009","EFO_0000275","EFO_0003821","EFO_0000249","EFO_0004278","EFO_0003758","EFO_1001249","EFO_1001413","EFO_0003885","MONDO_0002050","EFO_0004287","EFO_0000253","EFO_0000612","HP_0002019"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for cardiac arrhythmia and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1315633","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O.O","inchiKey":"ZOEFQKVADUBYKV-MCDZGGTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1315633","maximumClinicalTrialPhase":0,"parentId":"CHEMBL752","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50086848"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL132966","canonicalSmiles":"CNCC/C=C/c1cccnc1","inchiKey":"JUOSGGQXEBBCJB-GORDUTHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVANICLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rivanicline","TC-2403"],"crossReferences":{"PubChem":["26752048"],"drugbank":["DB05855"]},"childChemblIds":["CHEMBL2107367","CHEMBL1783879"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1350","canonicalSmiles":"O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O","inchiKey":"DKJJVAGXPKPDRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILUDRONIC ACID","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Skelid"],"synonyms":["SR 41319","SR-41319","Skelid","Tiludronate","Tiludronic Acid","Tiludronic acid"],"crossReferences":{"Wikipedia":["Tiludronic_acid"],"drugbank":["DB01133"],"chEBI":["9598"]},"childChemblIds":["CHEMBL1200448"],"count":2,"approvedIndications":["EFO_0004260"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for bone disease and has 1 investigational indication."}
{"id":"CHEMBL138806","canonicalSmiles":"O=C(O)C(=O)Nc1sc2c(c1C(=O)O)CCOC2","inchiKey":"SNNOZMNTPOIDSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL138806","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1437","canonicalSmiles":"NC[C@H](O)c1ccc(O)c(O)c1","inchiKey":"SFLSHLFXELFNJZ-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NOREPINEPHRINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levophed","Norepinephrine","R-norepinephrine"],"crossReferences":{"DailyMed":["norepinephrine%20bitartrate"],"PubChem":["144212261","26754493","26754494","29215339","50109852","50109853","57288371","90341660"],"Wikipedia":["Norepinephrine"],"drugbank":["DB00368"],"chEBI":["18357"]},"childChemblIds":["CHEMBL1356607","CHEMBL3273169","CHEMBL2311152","CHEMBL3248963","CHEMBL2130595","CHEMBL1434513"],"count":13,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0004610","EFO_0003888","EFO_0003777","EFO_0006859","HP_0002140","EFO_0006834","EFO_0005207","EFO_0005252","EFO_0000319","MONDO_0043771","EFO_0001073","HP_0100806","HP_0000083","HP_0100543","MP_0001845","MONDO_0002050","EFO_0003144","MONDO_0043510","HP_0031273","EFO_0005251"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for cardiovascular disease and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL144527","canonicalSmiles":"Fc1ccc(CC2CCNCC2)cc1","inchiKey":"JLAKCHGEEBPDQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-(4-Fluorobenzyl)Piperidine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(4-Fluorobenzyl)Piperidine"],"crossReferences":{"drugbank":["DB07110"]},"childChemblIds":["CHEMBL1204355","CHEMBL1802039"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1448280","canonicalSmiles":"CN1CCC[C@H]1c1cccnc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"QLDPCHZQQIASHX-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINE BITARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Nicotine Hydrogen Tartrate Salt"],"crossReferences":{"PubChem":["56463314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1454910","canonicalSmiles":"O=[N+]([O-])c1ccc(O)c2ncccc12","inchiKey":"RJIWZDNTCBHXAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROXOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-82","Nitrohydroxyquinoline","Nitroxoline"],"crossReferences":{"PubChem":["11532939","144205522","170466124","29216358","56423111"],"Wikipedia":["Nitroxoline"],"drugbank":["DB01422"],"chEBI":["67121"]},"childChemblIds":["CHEMBL3251404"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1546","canonicalSmiles":"CC(N)Cc1ccc(O)cc1","inchiKey":"GIKNHHRFLCDOEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYAMPHETAMINE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydroxyamfetamine","Hydroxyamphetamine"],"crossReferences":{"DailyMed":["hydroxyamphetamine%20hydrobromide"],"Wikipedia":["Hydroxyamfetamine"],"drugbank":["DB09352"]},"childChemblIds":["CHEMBL1200705"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969."}
{"id":"CHEMBL15511","canonicalSmiles":"CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1","inchiKey":"SPFYMRJSYKOXGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENROFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Baytril"],"synonyms":["BAY VP 2674","Enrofloxacin"],"crossReferences":{"PubChem":["104171364","144204382","170465572","26746921","50100858","56422205","855596"],"Wikipedia":["Enrofloxacin"],"drugbank":["DB11404"],"chEBI":["35720"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1563","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl","inchiKey":"GUGHGUXZJWAIAS-QQYBVWGSSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DAUNORUBICIN HYDROCHLORIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL178","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cerubidine","Daunorubicin hydrochloride","Daunoxome"],"synonyms":["Daunorubicin hydrochloride","FI 6339 HYDROCHLORIDE","FI 6339 [AS THE BASE]","FI-6339","FI-6339 HYDROCHLORIDE","NDC 0082-4155","NDC-0082-4155","NSC-82151","RP 13057 HYDROCHLORIDE","RP 13057 [AS THE BASE)","RP-13057","RP-13057 HYDROCHLORIDE"],"crossReferences":{"DailyMed":["daunorubicin%20hydrochloride"],"PubChem":["144208357","17389073","85273781","855543"]},"count":22,"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0003812","EFO_1001945","EFO_0000209","EFO_1001052","MONDO_0003541","EFO_0000565","EFO_0004251","EFO_0000330","MONDO_0020743","EFO_0000198","EFO_0000221","EFO_0003802","EFO_1001779","EFO_0000220","MONDO_0019457","EFO_0000222","EFO_0000223","EFO_1001946","MONDO_0000870","EFO_0000224","EFO_0003029","EFO_0003025","EFO_0003028","MONDO_0044917","EFO_1001936","EFO_0000574","EFO_1001947","EFO_0000218","EFO_0000691","EFO_1002001","EFO_0003027","EFO_0003811"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1582","canonicalSmiles":"C[C@@H]1C[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]32)CC1=O","inchiKey":"IKXILDNPCZPPRV-RFMGOVQKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROMOSTANOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dromostanolone"],"crossReferences":{"Wikipedia":["Drostanolone"],"drugbank":["DB00858"],"chEBI":["34838"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL160","canonicalSmiles":"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C","inchiKey":"PMATZTZNYRCHOR-CGLBZJNRSA-N","drugType":"Protein","blackBoxWarning":true,"name":"CYCLOSPORINE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capimune","Capsorin","Cequa","Cyclosporine","Deximune","Gengraf","Ikervis","Neoral","Optimmune","Restasis","Restasis multidose","Sandimmun","Sandimmune","Sangcya","Vanquoral"],"synonyms":["27-400","ANTIBIOTIC S-7481F1","Ciclosporin","Cyclosporin a","Cyclosporine","NSC-290193","OL-27-400","SANG-35","SDZ-OXL-400"],"crossReferences":{"DailyMed":["cyclosporine"],"PubChem":["11532934","144204218","144212166","170466812","26757675","56422786"],"TG-GATEs":["142"],"Wikipedia":["Ciclosporin"],"drugbank":["DB00091"],"chEBI":["4031"]},"count":114,"approvedIndications":["EFO_0003966","MP_0001845","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000196262"],"count":1},"linkedDiseases":{"rows":["EFO_0000365","EFO_0000681","EFO_0005952","MONDO_0018896","EFO_1001951","EFO_0000339","EFO_0003884","EFO_0007157","EFO_0000676","EFO_0000400","Orphanet_379","EFO_0000198","MONDO_0013730","MONDO_0019465","EFO_0009449","Orphanet_79213","EFO_1000906","HP_0000964","EFO_0001642","EFO_0004286","HP_0009926","MONDO_0008315","Orphanet_567","EFO_1000760","EFO_1001231","EFO_1001365","MONDO_0020290","MONDO_0009453","EFO_0000678","EFO_0000574","EFO_0001378","EFO_0001054","EFO_0000341","EFO_0000516","Orphanet_231214","EFO_1000550","EFO_0004214","EFO_0003086","Orphanet_84","EFO_0007183","EFO_0007451","Orphanet_104","MONDO_0007254","Orphanet_790","EFO_1001413","MONDO_0003541","EFO_0005676","EFO_0003966","MONDO_0002158","MONDO_0002898","EFO_0000183","EFO_0007527","EFO_1000388","EFO_0000616","EFO_0000694","MONDO_0019457","EFO_0000403","EFO_0004198","MONDO_0000870","EFO_0000319","EFO_0000222","EFO_0003818","MONDO_0019469","EFO_0004599","EFO_0004220","EFO_0000649","EFO_0000764","EFO_0006927","EFO_0007359","MONDO_0002367","EFO_0007141","EFO_0000557","MONDO_0018906","MONDO_0043510","EFO_0000763","EFO_0009492","EFO_0000729","Orphanet_309015","MONDO_0000873","EFO_0003777","EFO_0003780","MONDO_0000956","Orphanet_848","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0007160","EFO_0000544","EFO_0000389","MONDO_0019088","EFO_0000182","EFO_0000330","EFO_0000783","MONDO_0015540","EFO_1000785","EFO_0004276","EFO_1001156","EFO_0009441","EFO_0005761","EFO_0002687","EFO_0000220","HP_0001919","MONDO_0008170","EFO_0004236","EFO_0009708","MP_0001845","EFO_0006926","MONDO_0100096","MONDO_0021193","EFO_0001359","EFO_0002428","EFO_1001051","EFO_0001360","EFO_0000699","EFO_1000102","Orphanet_232","EFO_1000965","MONDO_0015686","EFO_0008507","EFO_0000274","HP_0001915","EFO_1001469","EFO_1002048","Orphanet_91378","EFO_1000690","EFO_0005531","MONDO_0001475","EFO_0004254","EFO_0003047","EFO_0009609","EFO_0000685","Orphanet_666","EFO_0000621","EFO_0000311","MONDO_0001705","EFO_0000095","EFO_0001421","EFO_0008583","EFO_1000560","EFO_0000612","MONDO_0020077","EFO_0003833","EFO_0000691"],"count":143},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 3 approved and 111 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1614702","canonicalSmiles":"COc1cc2c(cc1C(=O)N1CCC(Cc3ccc(F)cc3)CC1)c(C(=O)C(=O)N(C)C)cn2C","inchiKey":"JBNWDYGOTHQHOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCIO-323","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCIO-323","Scio-323"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL163238","canonicalSmiles":"Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2","inchiKey":"BCQTVJKBTWGHCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PILSICAINIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pilsicainide","Pilsicainide hydrochloride"],"crossReferences":{"PubChem":["144206011","170465988","50112708"],"Wikipedia":["Pilsicainide"],"drugbank":["DB12712"]},"childChemblIds":["CHEMBL4303511"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL165084","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"SQVRNKJHWKZAKO-PFQGKNLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL165084","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576699"],"Wikipedia":["Neuraminic_acid"],"drugbank":["DB04265"],"chEBI":["45744"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1675","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C","inchiKey":"VYGQUTWHTHXGQB-FFHKNEKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VITAMIN A PALMITATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afaxin","Alphalin","Aquasol a","Del-vi-a","Vi-dom-a","Vitamin a","Vitamin a palmitate","Vitamin a solubilized"],"synonyms":["Retinyl palmitate","Vitamin a palmitate"],"crossReferences":{"DailyMed":["vitamin%20a%20palmitate"],"PubChem":["144207001","144213325","26748810","57260141"],"chEBI":["17616"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1676","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF","inchiKey":"XTULMSXFIHGYFS-VLSRWLAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUTICASONE FUROATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arnuity ellipta","Avamys","Flonase sensimist allergy relief","Relvar ellipta","Trelegy ellipta","Veramyst"],"synonyms":["Fluticasone furoate","GSK 685 698","GSK-685968","GSK685968","GW-685698X","GW685698X"],"crossReferences":{"DailyMed":["fluticasone%20furoate"],"Wikipedia":["Fluticasone_furoate"],"drugbank":["DB08906"],"chEBI":["74899"]},"count":9,"approvedIndications":["EFO_0005854","HP_0006536","EFO_0000270","EFO_0000341","HP_0001742","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0006536","EFO_0008521","EFO_1000391","EFO_0000270","EFO_0007533","EFO_0000341","EFO_0007141","EFO_1001417","HP_0001742","EFO_0003918","EFO_0003956"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 6 approved and 3 investigational indications."}
{"id":"CHEMBL1697715","canonicalSmiles":"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O.O.O","inchiKey":"OMYIZCZQILAOGB-BYLXUVCXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOPERAZONE DIHYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL507674","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefoperazone Dihydrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL170988","canonicalSmiles":"N=C(N)NC(=N)NCCc1ccccc1","inchiKey":"ICFJFFQQTFMIBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENFORMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," Germany"," France"],"classes":["Metabolism toxicity"],"year":1977},"tradeNames":[],"synonyms":["Phenformin"],"crossReferences":{"PubChem":["11112448","124882390","174006812"],"Wikipedia":["Phenformin"],"drugbank":["DB00914"],"chEBI":["8064"]},"childChemblIds":["CHEMBL2348409","CHEMBL1528839"],"count":2,"approvedIndications":["EFO_0000400"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for diabetes mellitus and has 1 investigational indication. It was withdrawn in United States,  Germany and  France initially in 1977 due to Metabolism toxicity."}
{"id":"CHEMBL1714","canonicalSmiles":"CNC1(c2ccccc2Cl)CCCCC1=O.Cl","inchiKey":"VCMGMSHEPQENPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KETAMINE HYDROCHLORIDE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL742","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anaket-V","Ketalar","Ketamine hydrochloride","Ketanest","Ketavet","Vetalar"],"synonyms":["CI-581","CL 369","CL-369","CN-52,372-2","CN-52372-2","CN-523722","Ketamine hydrochloride","Ketamine hydrochloride ciii"],"crossReferences":{"DailyMed":["ketamine%20hydrochloride"],"chEBI":["650657"]},"count":13,"linkedTargets":{"rows":["ENSG00000161509","ENSG00000273079","ENSG00000116032","ENSG00000183454","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0004320","MONDO_0000726","HP_0000360","EFO_0002610","HP_0000989","HP_0012532","MONDO_0002009","EFO_0003015","EFO_0009658","EFO_0009963","EFO_1001884","EFO_0003843","EFO_0003829","EFO_0000311","EFO_0000546","MP_0001914","HP_0100543","EFO_0000289","MONDO_0002050","EFO_0003931","EFO_0003761","EFO_0005611","HP_0030680"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 13 investigational indications."}
{"id":"CHEMBL1724","canonicalSmiles":"C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1.[Br-]","inchiKey":"JRRNZNSGDSFFIR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPENZOLATE BROMIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL524004","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cantil"],"synonyms":["Glycophenylate","Mepenzolate","Mepenzolate Bromide","Mepenzolate bromide","Mepenzolate methylbromide","Mepenzolone bromide"],"crossReferences":{"PubChem":["144203918","170465214","26748120","49648464"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1742999","drugType":"Antibody","blackBoxWarning":false,"name":"CARLUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNTO 888","CNTO-888","Carlumab"],"count":3,"linkedTargets":{"rows":["ENSG00000108691"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315","EFO_0009448","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743000","drugType":"Antibody","blackBoxWarning":false,"name":"CITATUZUMAB BOGATOX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Citatuzumab bogatox","VB6-845"],"count":1,"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL175633","canonicalSmiles":"CC(C)N1CCN(c2ccc(N3CCN(c4ccc(OC[C@H]5OC[C@](Cn6cncn6)(c6ccc(F)cc6F)O5)cc4)CC3)cc2)C1=O","inchiKey":"AEKNYBWUEYNWMJ-QWOOXDRHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMICONAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pramiconazole","R126638"],"crossReferences":{"drugbank":["DB06295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1765508","canonicalSmiles":"O=C(N[C@H]1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@H](Cc2ccc(Cl)cc2)C1)c1ccnc2ccccc12","inchiKey":"NXLUTEDAEFXMQR-BJKOFHAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPERGUALIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Spergualin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL180022","canonicalSmiles":"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C","inchiKey":"JWNPDZNEKVCWMY-VQHVLOKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERATINIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CDP-820","HKI-272","Neratinib","WAY-179272"],"crossReferences":{"DailyMed":["neratinib%20maleate"],"PubChem":["124950160"],"Wikipedia":["Neratinib"],"drugbank":["DB11828"]},"childChemblIds":["CHEMBL3989921"],"count":10,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_1001480","EFO_0003968","MONDO_0008170","MONDO_0007254","EFO_0000313","EFO_0000305","EFO_0003060","EFO_1000984","EFO_0000519","EFO_1001951"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for neoplasm and has 9 investigational indications."}
{"id":"CHEMBL1829174","canonicalSmiles":"Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OC[C@H]3CC(=O)O)c1","inchiKey":"BZCALJIHZVNMGJ-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FASIGLIFAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fasiglifam","TAK-875"],"crossReferences":{"drugbank":["DB12491"]},"childChemblIds":["CHEMBL2047171","CHEMBL2047159"],"count":2,"linkedTargets":{"rows":["ENSG00000126266"],"count":1},"linkedDiseases":{"rows":["HP_0011015","EFO_0001360","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1835919","canonicalSmiles":"Nc1ncnc2c1C(=O)N(c1ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc1)CCO2","inchiKey":"GEVVQZHMFVFGLN-HDJSIYSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04620110","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04620110","PF-4620110","Pf-04620110"],"crossReferences":{"drugbank":["DB14887"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1908360","canonicalSmiles":"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C","inchiKey":"HKVAMNSJSFKALM-GKUWKFKPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EVEROLIMUS","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afinitor","Afinitor disperz","Certican","Votubia","Zortress"],"synonyms":["Everolimus","RAD 666","RAD-001","RAD-666","RAD001","SDZ-RAD"],"crossReferences":{"DailyMed":["everolimus"],"PubChem":["144206063"],"drugbank":["DB01590"],"chEBI":["68478"]},"count":128,"approvedIndications":["EFO_0000616","EFO_0005220","EFO_0003869","EFO_1001901","EFO_0000681","EFO_0000349","MONDO_0007254","HP_0009720","EFO_0000540","EFO_0002890","EFO_0000305","EFO_0000272","EFO_0000311","MONDO_0016693","Orphanet_805","EFO_0002499","EFO_1000045"],"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["EFO_1000256","EFO_0000637","EFO_0000365","EFO_0000558","EFO_0000681","EFO_0005952","Orphanet_306498","EFO_0000632","EFO_1001951","EFO_0000339","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_0003884","MONDO_0020732","MONDO_0015277","EFO_0000514","Orphanet_2495","EFO_1000882","EFO_0000760","MONDO_0002715","EFO_0000198","EFO_0002618","MONDO_0013730","MONDO_0021054","Orphanet_636","EFO_1001968","EFO_1001496","MONDO_0008315","EFO_0005221","EFO_1000026","MONDO_0021639","MONDO_0002691","EFO_1001231","EFO_0000630","MONDO_0020290","Orphanet_398934","Orphanet_2869","EFO_0000574","EFO_0001378","EFO_0001376","EFO_0005672","EFO_0001062","EFO_0003086","EFO_0001365","EFO_0007451","EFO_0002913","MONDO_0007254","EFO_0001071","EFO_0004252","MONDO_0001056","MONDO_0002158","MONDO_0002898","EFO_1000630","EFO_0004289","Orphanet_805","EFO_0000326","EFO_0002499","EFO_0000183","MONDO_0003478","EFO_0000616","EFO_0005220","EFO_0003897","EFO_0006859","EFO_1000601","EFO_0002916","EFO_0007331","MONDO_0024503","EFO_0001645","EFO_0000403","Orphanet_44890","EFO_0000222","MONDO_0007576","EFO_0004599","EFO_0003896","MONDO_0002120","MONDO_0002603","EFO_0000764","MONDO_0011962","EFO_0000702","MONDO_0002367","EFO_1000852","EFO_0000763","EFO_1001927","MONDO_0024880","EFO_0000519","EFO_0003869","MONDO_0000873","EFO_0003046","EFO_0000228","EFO_0000540","EFO_0000333","EFO_0003913","EFO_0000565","EFO_0000544","HP_0001871","MONDO_0003268","EFO_0000389","EFO_0000182","MONDO_0005411","Orphanet_637","EFO_1000045","EFO_0009441","MONDO_0000447","EFO_0008620","EFO_0000220","MONDO_0002108","EFO_0004224","MONDO_0008170","EFO_0000349","Orphanet_3389","EFO_0009708","MONDO_0015917","EFO_0005537","EFO_0006544","MONDO_0021640","MONDO_0009348","EFO_0002970","EFO_1001901","EFO_1001469","MONDO_0021063","MONDO_0002087","Orphanet_538","EFO_0000305","EFO_1002048","EFO_0000272","EFO_0000231","MONDO_0001187","HP_0000083","EFO_1001480","EFO_1000044","EFO_0000474","EFO_1000218","MONDO_0041161","EFO_0003860","EFO_0000770","EFO_0002626","Orphanet_93460","EFO_0003047","EFO_0002617","EFO_1000158","EFO_1000616","MONDO_0016586","EFO_0000313","EFO_0004243","HP_0009720","EFO_0003060","EFO_0000311","EFO_0003863","MONDO_0016693","EFO_0006861","EFO_0003833","EFO_0000691","MONDO_0021637","EFO_0000181","MONDO_0001422"],"count":156},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 17 approved and 111 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1963685","drugType":"Unknown","blackBoxWarning":false,"name":"LUCINACTANT","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Surfaxin"],"synonyms":["ATI 02","ATI-02","KL4-SURFACTANT","Lucinactant"],"crossReferences":{"DrugCentral":["4232"]},"count":5,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 5 investigational indications."}
{"id":"CHEMBL203567","canonicalSmiles":"Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1","inchiKey":"IJDQETGUEUJVTB-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RO-3201195","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ro-3201195"],"crossReferences":{"drugbank":["DB08424"],"chEBI":["45116"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2047171","canonicalSmiles":"Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc([14CH2]Oc2ccc3c(c2)OC[C@H]3CC(=O)O)c1","inchiKey":"BZCALJIHZVNMGJ-JYFLCFGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2047171","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1829174","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103802","canonicalSmiles":"CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1.C[C@H](O)CO.O","inchiKey":"GOADIQFWSVMMRJ-UPGAGZFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPAGLIFLOZIN PROPYLENE GLYCOL","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL429910","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Farxiga"],"synonyms":["BMS-512148-05","Dapagliflozin","Dapagliflozin propanediol","Dapagliflozin propylene glycol"],"crossReferences":{"chEBI":["85079"]},"count":2,"approvedIndications":["EFO_0001360"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0001359","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for type ii diabetes mellitus and has 1 investigational indication."}
{"id":"CHEMBL2103815","canonicalSmiles":"CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C","inchiKey":"NYGCNONRVCGHAT-UFIKZEAMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LARAZOTIDE ACETATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2105646","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-1001","AT-1001 (LARAZOTIDE ACETATE)","Larazotide acetate"],"count":1,"linkedTargets":{"rows":["ENSG00000117971","ENSG00000080644"],"count":2},"linkedDiseases":{"rows":["EFO_0001060"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2103879","canonicalSmiles":"CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O","inchiKey":"RVAQIUULWULRNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANETESPIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ganetespib","STA 9090","STA-9090"],"crossReferences":{"drugbank":["DB12047"]},"count":23,"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","MONDO_0015686","EFO_0000571","EFO_0000756","MONDO_0008170","Orphanet_44890","MONDO_0007254","EFO_1000657","EFO_0000222","MONDO_0007576","MONDO_0021063","EFO_0003060","MONDO_0001056","MONDO_0002158","EFO_1000044","EFO_0003968","EFO_0006861","EFO_0000770","MONDO_0008903","EFO_0000182","EFO_0000673","EFO_0000702","EFO_0001378","EFO_0000760"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 23 investigational indications."}
{"id":"CHEMBL2105373","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)CCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"OZZAYJQNMKMUSD-DMISRAGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREGNENOLONE SUCCINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Formula 405"],"synonyms":["Pregnenolone","Pregnenolone succinate"],"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2106123","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Ca+2].[Ca+2].[Ca+2]","inchiKey":"FNAQSUUGMSOBHW-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM CITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Citracal"],"synonyms":["Calcium citrate","Calcium citrate tetrahydrate","E-333(III)","INS NO.333(III)","INS-333(III)"],"crossReferences":{"DrugCentral":["4479"],"drugbank":["DB11093"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2106165","canonicalSmiles":"CNCCC(c1cccc(F)c1)c1cccc(F)c1.Cl","inchiKey":"MGNMVYXIKDNAKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELUCEMINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110814","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delucemine hydrochloride","NPS 1506·HCL"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106633","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Mg+2]","inchiKey":"HQKMJHAJHXVSDF-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM STEARATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium stearate"],"crossReferences":{"drugbank":["DB14077"],"chEBI":["9254"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106972","canonicalSmiles":"O=C(Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1)c1cccs1","inchiKey":"SSLHKNBKUBAHJY-HDJSIYSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NELTENEXINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neltenexine"],"crossReferences":{"drugbank":["DB13239"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107807","canonicalSmiles":"Cc1nccn1C[C@H]1CCc2c(c3cccc4c3n2CCC4)C1=O.Cl","inchiKey":"PGMSXNFJFNKUGN-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILANSETRON HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103778","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilansetron hydrochloride","DU123265","KC-9946"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108081","drugType":"Protein","blackBoxWarning":false,"name":"TRAFERMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fiblast"],"synonyms":["CAB-2001","Trafermin"],"count":3,"linkedTargets":{"rows":["ENSG00000066468"],"count":1},"linkedDiseases":{"rows":["EFO_1001459","EFO_0009472","EFO_0000649"],"count":3},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108086","drugType":"Unknown","blackBoxWarning":false,"name":"SULODEXIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulodexide"],"crossReferences":{"DrugCentral":["4726"]},"count":8,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2108183","drugType":"Small molecule","blackBoxWarning":false,"name":"CRILANOMER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crilanomer"],"crossReferences":{"DrugCentral":["4854"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108568","drugType":"Protein","blackBoxWarning":false,"name":"TREBANANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 386","AMG-386","Tovasanib","Trebananib"],"count":14,"linkedTargets":{"rows":["ENSG00000091879","ENSG00000154188"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0015686","MONDO_0008170","EFO_0000681","EFO_1001465","MONDO_0007254","MONDO_0002087","EFO_0003060","EFO_0000632","MONDO_0002158","EFO_1000218","EFO_0003968","EFO_0000182","EFO_0008528","EFO_0000673","EFO_1000158"],"count":16},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL2108632","drugType":"Unknown","blackBoxWarning":false,"name":"PLATELETS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Platelets"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108676","drugType":"Enzyme","blackBoxWarning":true,"name":"ELOSULFASE ALFA","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bmn 110, rhgalns, n-acetylgalactosamine-6-sulfatase, chondroitinsulfatase, galactose-6-sulfate sulfatase, ec=3.1.6.4","Vimizim"],"synonyms":["BMN 110","BMN-110","Elosulfase alfa","RHGALNS"],"crossReferences":{"DailyMed":["elosulfase%20alfa"],"DrugCentral":["4999"]},"count":1,"approvedIndications":["Orphanet_309297"],"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for mucopolysaccharidosis type 4a. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2109249","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-557","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-557","Amg-557","MEDI-5872","Medi 5872","Prezalumab"],"count":4,"linkedTargets":{"rows":["ENSG00000160223"],"count":1},"linkedDiseases":{"rows":["EFO_0003834","EFO_0002690","EFO_0000676","EFO_0000699"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109354","drugType":"Antibody","blackBoxWarning":false,"name":"MONO-DGA-RFB4","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MONO-DGA-RFB4","Mono-dga-rfb4"],"count":1,"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109481","drugType":"Antibody","blackBoxWarning":false,"name":"ICM3","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ICM3"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109482","drugType":"Antibody","blackBoxWarning":false,"name":"BI-505","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI-505","Bi-505"],"count":1,"linkedTargets":{"rows":["ENSG00000090339"],"count":1},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109513","drugType":"Antibody","blackBoxWarning":false,"name":"PD-360324","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-360324","Pd-360324"],"count":6,"linkedTargets":{"rows":["ENSG00000184371"],"count":1},"linkedDiseases":{"rows":["EFO_0003834","EFO_0000685","EFO_0001075","MONDO_0015686","EFO_1000251","DOID_13406","EFO_0000311"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109536","drugType":"Antibody","blackBoxWarning":false,"name":"KB-001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Humaneered"],"synonyms":["KB-001","Kb-001"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109569","drugType":"Antibody","blackBoxWarning":false,"name":"AUROGRAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aurograb"],"synonyms":["Aurograb"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109607","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-8968","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-8968","Medi-8968"],"count":2,"linkedTargets":{"rows":["ENSG00000115594"],"count":1},"linkedDiseases":{"rows":["EFO_1000710","EFO_0000341"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109621","drugType":"Antibody","blackBoxWarning":false,"name":"ABITUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALD403","Abituzumab","DI 17E6","DI-17E6","DI17E6","EMD 525797","EMD-525797"],"count":5,"linkedTargets":{"rows":["ENSG00000138448"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","MONDO_0008170","EFO_0004244","EFO_0000717","MONDO_0008315","EFO_1001951"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2110579","canonicalSmiles":"CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1","inchiKey":"VQPFSIRUEPQQPP-MXBOTTGLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAMORELIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anamorelin","RC-1291","ST-1291"],"crossReferences":{"drugbank":["DB06645"]},"childChemblIds":["CHEMBL2103794"],"count":2,"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["HP_0004326","HP_0012378","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2110602","canonicalSmiles":"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CC#N)[C@H]2SC1","inchiKey":"RRYMAQUWDLIUPV-BXKDBHETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHACETRILE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefacetrile"],"crossReferences":{"drugbank":["DB01414"]},"childChemblIds":["CHEMBL2104099"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL213490","canonicalSmiles":"O=P(O)(O)C(O)(Cc1cccc(-c2cccc(-c3ccccc3)c2)c1)P(=O)(O)O","inchiKey":"YXQQNSYZOQHKHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(1-Hydroxy-1-Phosphono-2-[1,1';3',1'']Terphenyl-3-Yl-Ethyl)-Phosphonic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(1-Hydroxy-1-Phosphono-2-[1,1';3',1'']Terphenyl-3-Yl-Ethyl)-Phosphonic Acid"],"crossReferences":{"drugbank":["DB07404"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2140942","canonicalSmiles":"COc1ccc2[nH]cc(CCN(C(C)C)C(C)C)c2c1","inchiKey":"DNBPMBJFRRVTSJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2140942","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124954085"],"drugbank":["DB01441"],"chEBI":["48282"]},"childChemblIds":["CHEMBL2357882"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL215344","canonicalSmiles":"c1ccc(CNc2c3c(nc4ccccc24)CCCC3)cc1","inchiKey":"JYJAEHAURXXPSD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL215344","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03672"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2159354","canonicalSmiles":"[3H]c1c(-c2cc(Cl)cc(Cl)c2)nn([C@@H](C)c2ccc(C(=O)NCCC(=O)O)cc2)c1-c1ccc2c([3H])c(OC)ccc2c1","inchiKey":"DNTVJEMGHBIUMW-PTKKZTCJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2159354","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1933349","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2160007","canonicalSmiles":"CCOc1nc(N)nc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(OC(C)C)O[C@H]2[C@@]1(C)F","inchiKey":"PVRFQJIRERYGTQ-UYISCHNFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSI-352938","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-0938","GS0938","Gs-0938","PSI-352938","PSI-938","PSI352938","PSI938","Psi-352938"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL217914","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2cc3ccc(Cl)cc3s2)C1=O","inchiKey":"PHLKBODTBJLXRD-WFASDCNBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL217914","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07844"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221118","canonicalSmiles":"Nc1cccc(CCc2ccc3cc[nH]c3c2)n1","inchiKey":"OSHSZKRWKLQZBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221118","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07206"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219417","canonicalSmiles":"O=CN(CC(O)CN(C=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"BFVVDRUCXCIALU-UHFFFAOYSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"IOFORMINOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AN-113111","FEK-256-062","GE-145","Ioforminol"],"crossReferences":{"drugbank":["DB12439"]},"description":"Unknown drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL232201","canonicalSmiles":"CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1","inchiKey":"CZCHIEJNWPNBDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZIODARONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," France"],"classes":["Hepatotoxicity"],"year":1964},"tradeNames":[],"synonyms":["Benziodarone","L 2329"],"crossReferences":{"PubChem":["144205346","170465852","29216089"],"TG-GATEs":["130"],"Wikipedia":["Benziodarone"],"drugbank":["DB13277"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000198668"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease. It was withdrawn in United Kingdom and  France initially in 1964 due to Hepatotoxicity."}
{"id":"CHEMBL2325014","canonicalSmiles":"Nc1[nH]ncc1-c1cc(Cl)ccc1Oc1cc(F)c(S(=O)(=O)Nc2cscn2)cc1Cl","inchiKey":"ZYSCOUXLBXGGIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2325014","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL232557","canonicalSmiles":"Cc1cc(N2CCCS2(=O)=O)c2oc(-c3ccc(O)c(O)c3)c(O)c(=O)c2c1","inchiKey":"CEXBEGBNDJVZPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL232557","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07024"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2326966","canonicalSmiles":"N=C(N)NCCC[C@H](NC(=O)CCC(=O)OC[N+]1(c2cc(=O)c3cccc(-c4ccccc4)c3o2)CCOCC1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)[O-]","inchiKey":"SVNJBEMPMKWDCO-KCHLEUMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SF-1126","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SF 1126","SF-1126","SF-1126 INNER SALT","Sf-1126"],"count":4,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000182","EFO_0000621","EFO_0000181","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL23330","canonicalSmiles":"NC(=O)c1cc(N2CC2)c([N+](=O)[O-])cc1[N+](=O)[O-]","inchiKey":"WOCXQMCIOTUMJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRETAZICAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-1954","NSC-115829","Tretazicar"],"crossReferences":{"PubChem":["11110923","17404763","411933","46500339","50105941","50105942","85230965","90341816"],"drugbank":["DB04253"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL236593","canonicalSmiles":"O=C(N[C@@H]1CC[C@@H](c2cccc(F)c2F)CN(CC(F)(F)F)C1=O)N1CCC(n2c(O)nc3ncccc32)CC1","inchiKey":"CGDZXLJGHVKVIE-DNVCBOLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELCAGEPANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0974","MK0974","Mk-0974","Telcagepant"],"crossReferences":{"Wikipedia":["Telcagepant"],"drugbank":["DB12228"]},"childChemblIds":["CHEMBL2105656"],"count":1,"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL236687","canonicalSmiles":"C=C(C)[C@@H]1CC=C(CO)CC1","inchiKey":"NDTYTMIUWGWIMO-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERILLYL ALCOHOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 2664","NSC-641066","Perillyl alcohol"],"crossReferences":{"PubChem":["500472","93576954"],"drugbank":["DB15289"],"chEBI":["10782"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL236718","canonicalSmiles":"Oc1ccc([C@@H]2Oc3ccc(O)cc3[C@@H]3CC(F)(F)C[C@@H]32)cc1","inchiKey":"QJSMFUTULGSHNQ-ZOBUZTSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL236718","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07638"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL244888","canonicalSmiles":"O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1ccc(O)cc1","inchiKey":"YCWSUKQGVSGXJO-NTUHNPAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFUROXAZIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ercefuryl 200"],"synonyms":["Nifuroxazide","RC-27109","SJ000287313"],"crossReferences":{"Wikipedia":["Nifuroxazide"],"drugbank":["DB13855"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL245678","canonicalSmiles":"CN1CCc2nc(C(=O)N[C@@H]3CCCC[C@@H]3NC(=O)c3cc4cc(Cl)ccc4[nH]3)sc2C1","inchiKey":"ARPFWVKYXJZULB-DLBZAZTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL245678","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07629"]},"childChemblIds":["CHEMBL556396"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24828","canonicalSmiles":"COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1","inchiKey":"UHTHHESEBZOYNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VANDETANIB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","Vandetanib","ZD-64","ZD-6474","ZD6474"],"crossReferences":{"DailyMed":["vandetanib"],"PubChem":["103905338","124893338","144206064","170465617","50100123","50112766"],"Wikipedia":["Vandetanib"],"drugbank":["DB05294"],"chEBI":["49960"]},"childChemblIds":["CHEMBL533849"],"count":46,"approvedIndications":["EFO_0000616","EFO_0003841","EFO_0002892","MONDO_0002108","EFO_0000641","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000165731","ENSG00000106123","ENSG00000065361","ENSG00000037280","ENSG00000120156","ENSG00000146904","ENSG00000135333","ENSG00000178568","ENSG00000196411","ENSG00000142627","ENSG00000044524","ENSG00000116106","ENSG00000101213","ENSG00000146648","ENSG00000102755","ENSG00000070886","ENSG00000080224","ENSG00000182580","ENSG00000145242","ENSG00000183317","ENSG00000141736","ENSG00000154928","ENSG00000197122","ENSG00000133216"],"count":25},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000365","MONDO_0004192","EFO_1001465","MONDO_0007254","EFO_1000657","MONDO_0002087","MONDO_0020654","EFO_1001951","MONDO_0001187","MONDO_0001056","MONDO_0002158","EFO_0000588","MONDO_0008903","EFO_0000182","EFO_0000501","MONDO_0044710","EFO_0000641","MONDO_0015277","EFO_0002499","EFO_1000158","EFO_0000616","EFO_0002618","EFO_0006859","EFO_0002916","MONDO_0002108","MONDO_0008170","EFO_0000349","Orphanet_44890","EFO_0000222","EFO_0002501","EFO_0007535","MONDO_0008627","EFO_0003060","MONDO_0008315","EFO_0000621","EFO_0001663","EFO_0009708","EFO_0000311","MONDO_0015917","EFO_1000489","EFO_0000630","EFO_1000026","EFO_0003841","EFO_0002892","EFO_0000702","MONDO_0002367","EFO_0006544","EFO_0001378","MONDO_0024880","EFO_0000181","MONDO_0021637","EFO_0000519"],"count":53},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 6 approved and 40 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL267044","canonicalSmiles":"CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC","inchiKey":"BGRJTUBHPOOWDU-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOSULPIRIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levosulpiride","Sulpiride l-form"],"crossReferences":{"PubChem":["11112626","11113767","170465834","26719874","50104627"],"Wikipedia":["Levosulpiride"],"chEBI":["64119"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL281593","canonicalSmiles":"N=C(N)NCC(=O)O","inchiKey":"BPMFZUMJYQTVII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANIDINO ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanidinoacetic Acid"],"crossReferences":{"Wikipedia":["Glycocyamine"],"drugbank":["DB02751"],"chEBI":["16344"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL291678","canonicalSmiles":"NC(=O)C[C@@H]1NC(=O)C2(CCCCC2)NC(=O)C[C@@H](c2ccc(CP(=O)(O)O)cc2)/C=C/C[C@@H](Cc2cccc3ccccc23)CNC1=O","inchiKey":"RHYFMOCFCFUTNH-GZNVFMSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL291678","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03276"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL304383","canonicalSmiles":"CNCC(=O)O","inchiKey":"FSYKKLYZXJSNPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARCOSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylamino-Acetic Acid","Sarcosine"],"crossReferences":{"PubChem":["57264366"],"Wikipedia":["Sarcosine"],"drugbank":["DB12519"],"chEBI":["15611"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3185220","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O","inchiKey":"UGMCXQCYOVCMTB-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185220","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206641"],"drugbank":["DB01375"],"chEBI":["31197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3233142","canonicalSmiles":"CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"LHAPOGAFBLSJJQ-GUTACTQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMATEPERONE TOSYLATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3306803","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Caplyta"],"synonyms":["ITI-007 tosylate","Lumateperone tosylate"],"crossReferences":{"DailyMed":["lumateperone%20tosylate"]},"count":1,"approvedIndications":["EFO_0000692"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for schizophrenia."}
{"id":"CHEMBL3301676","canonicalSmiles":"CC(=O)O.C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N2","inchiKey":"KWFNVZFWXXEJKL-YZDVLOIKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LINACLOTIDE ACETATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3301675","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Linaclotide acetate","MD-1100 ACETATE","MM-416775"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL34076","canonicalSmiles":"Nc1[nH]c(=O)[nH]c(=O)c1N","inchiKey":"BBTNLADSUVOPPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL34076","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03826"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544941","drugType":"Small molecule","blackBoxWarning":false,"name":"RG7185","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RO5271983","Rg7185"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544961","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-853520","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bi-853520"],"count":1,"linkedTargets":{"rows":["ENSG00000169398"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544972","canonicalSmiles":"CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c([O-])c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C.CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c([O-])c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C.[Ca+2]","inchiKey":"HEJBMFPJLCJWER-CWPVBXIBSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"NOVOBIOCIN CALCIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL36506","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Novobiocin calcium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544985","canonicalSmiles":"COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[n-]c2=O)cc1C(C)(C)C.O.[Na+]","inchiKey":"SJHKKWUESHNTBB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DASABUVIR SODIUM","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3137312","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dasabuvir sodium"],"count":2,"approvedIndications":["EFO_0004220","EFO_0003047"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for chronic hepatitis c virus infection and hepatitis c virus infection."}
{"id":"CHEMBL3545117","drugType":"Small molecule","blackBoxWarning":false,"name":"AVE-9940","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ave-9940"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545237","canonicalSmiles":"C#C[C@]1(O)CCC2C3CCC4CC(O)CC[C@]4(C)C3CC[C@@]21C","inchiKey":"CKAXZOYFIHQCBN-UQOAMHMYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HE3235","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Apotone"],"synonyms":["HE-3235","He3235"],"count":1,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545250","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2269557","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2269557","GSK2269557","Gsk-2269557"],"count":2,"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545254","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=NO)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"QNTASHOAVRSLMD-GYKMGIIDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLESOXIME","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-21311","Olesoxime","TRO-19622","TRO19622"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3545396","canonicalSmiles":"COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1","inchiKey":"CSGQVNMSRKWUSH-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-690514","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms 690514","Bms-690514"],"crossReferences":{"drugbank":["DB11665"]},"count":3,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000178568","ENSG00000141736"],"count":6},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0003060","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL360998","canonicalSmiles":"CN(C)Cc1ccc(-c2cccnc2)o1","inchiKey":"PJHSLLRNPASXIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360998","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07609"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL365845","canonicalSmiles":"CC(C)c1c(OC#CC2CC2)c2cc(F)ccc2[nH]c1=O","inchiKey":"YVJFHKQYMKKIHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL365845","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07864"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707247","canonicalSmiles":"CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N","inchiKey":"XRVDGNKRPOAQTN-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OZANIMOD","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ozanimod","RPC-1063","RPC1063"],"crossReferences":{"DailyMed":["ozanimod%20hydrochloride"],"drugbank":["DB12612"]},"childChemblIds":["CHEMBL3707246"],"count":4,"approvedIndications":["EFO_0000540"],"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0000729","MONDO_0100096","EFO_0001421","EFO_0000540","EFO_0000384"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for immune system disease and has 3 investigational indications."}
{"id":"CHEMBL3707378","drugType":"Small molecule","blackBoxWarning":false,"name":"CB-189625","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-625","Cb-189625"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707383","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"MONGERSEN SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GED-0301","GED-0301 SODIUM","Mongersen sodium"],"count":2,"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707386","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS TARTRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferrous tartrate"],"crossReferences":{"DrugCentral":["4545"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707402","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06372865","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-06372865"],"count":2,"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000182256","ENSG00000102287","ENSG00000022355","ENSG00000094755","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_1001892","HP_0003419","EFO_1001146"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707409","canonicalSmiles":"N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1.O=C(O)CCCCC(=O)O","inchiKey":"CEGWJIQFBNFMHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITACITINIB ADIPATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3622820","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB-039110 ADIPATE","INCB039110 adipate","Itacitinib adipate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707448","canonicalSmiles":"C1N2CN3CN1CN(C2)C3.N#C[S-].N#C[S-].[Ca+2]","inchiKey":"MYCYALXPHWPBMJ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM HEXAMINE THIOCYANATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201270","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium hexamine thiocyanate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3764608","canonicalSmiles":"COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)[O-])cn(C3CC3)c12.[K+]","inchiKey":"SPMVFGYQGKQFSW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3764608","maximumClinicalTrialPhase":0,"parentId":"CHEMBL31","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3793364","canonicalSmiles":"CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2.O=C(O)C(O)C(O)C(=O)O","inchiKey":"NOEWKFYGOQFKTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3793364","maximumClinicalTrialPhase":0,"parentId":"CHEMBL204021","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833301","canonicalSmiles":"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O.CNC(C)CC1CCCCC1","inchiKey":"MJCBWPMBFCUHBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BARBEXACLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maliasin"],"synonyms":["Barbexaclone"],"crossReferences":{"DrugCentral":["4345"]},"count":1,"approvedIndications":["EFO_0000474"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for epilepsy."}
{"id":"CHEMBL383705","canonicalSmiles":"CC(C)[C@H](N)C(=O)N1CCCC1","inchiKey":"IHBAVXVTGLANPI-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383705","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01884"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989529","canonicalSmiles":"CCCCCCCC/C=C\\CCCCCCCC(=O)O.NCCO","inchiKey":"KGWDUNBJIMUFAP-KVVVOXFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHANOLAMINE OLEATE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ethamolin"],"synonyms":["Ethanolamine oleate"],"crossReferences":{"DailyMed":["ethanolamine%20oleate"],"drugbank":["DB06689"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and has 1 investigational indication."}
{"id":"CHEMBL3989892","name":"CHEMBL3989892","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13841"]}}
{"id":"CHEMBL3989917","canonicalSmiles":"Cc1ccccc1-c1cc(N2CC[N+](C)(COP(=O)([O-])O)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"HZIYEEMJNBKMJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSNETUPITANT","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["07-PNET","Fosnetupitant"],"crossReferences":{"DailyMed":["fosnetupitant%20chloride%20hydrochloride"],"drugbank":["DB14019"]},"childChemblIds":["CHEMBL3989919"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","HP_0002013"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018."}
{"id":"CHEMBL406819","canonicalSmiles":"O=[N+]([O-])/N=C1\\NCCN1Cc1ccc(Cl)nc1","inchiKey":"YWTYJOPNNQFBPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDACLOPRID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidacloprid"],"crossReferences":{"PubChem":["144204850","144206909","144211345","170465741","26757127","29217927","50086524"],"Wikipedia":["Imidacloprid"],"drugbank":["DB11421"],"chEBI":["5870"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4086143","canonicalSmiles":"O=C1CC(c2c[nH]c3ccc(F)cc23)C(=O)N1","inchiKey":"MXKLDYKORJEOPR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06840003","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06840003","Pf-06840003"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4175981","canonicalSmiles":"CC(C)(C)[C@@H](CO)NC(=O)c1nn(-c2c[n+]([O-])ccn2)c2c1C[C@@H]1C[C@H]21","inchiKey":"ACSQLTBPYZSGBA-GMXVVIOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLORINAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APD-371","APD371","Apd371","Olorinab"],"crossReferences":{"drugbank":["DB14998"]},"count":3,"linkedTargets":{"rows":["ENSG00000188822"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0003766","EFO_0000384"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL419380","canonicalSmiles":"O=C(OCCN1CCCCCC1)C(c1ccsc1)C1CCCCC1","inchiKey":"MMNICIJVQJJHHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETIEDIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetiedil"],"crossReferences":{"drugbank":["DB13753"],"chEBI":["34619"]},"childChemblIds":["CHEMBL1968477","CHEMBL2112496"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL428647","canonicalSmiles":"CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C","inchiKey":"RCINICONZNJXQF-MZXODVADSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PACLITAXEL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["ABI-007","BMS 181339-01","BMS-181339-01","DHP 107","MBT 0206","NK 105","NSC-125973","Paclitaxel","QW-8184","Taxol"],"crossReferences":{"DailyMed":["paclitaxel"],"PubChem":["124893045","144205660","418145","56463361"],"drugbank":["DB01229"],"chEBI":["45863"]},"count":136,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_1000419","EFO_1000403","EFO_0000365","EFO_0003859","EFO_0000558","EFO_0000756","EFO_0000681","EFO_1000231","EFO_0005952","EFO_0000308","MONDO_0044704","EFO_1000984","EFO_0002917","EFO_1001951","EFO_1001952","MONDO_0001416","EFO_0000178","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_1000251","MONDO_0001528","EFO_0008528","EFO_0000676","EFO_1000532","EFO_0000514","MONDO_0018352","MONDO_0002601","MONDO_0002715","EFO_0002618","EFO_1001931","EFO_0005922","EFO_0000180","EFO_1001512","EFO_1001968","EFO_0005221","MONDO_0008315","EFO_0002496","MONDO_0001879","EFO_1001967","Orphanet_398934","MONDO_0002691","EFO_1000489","MONDO_0000544","EFO_0006818","MONDO_0018201","EFO_0004284","EFO_0008524","EFO_0000574","EFO_0001378","EFO_1000796","EFO_1000412","MONDO_0018171","EFO_0000292","MONDO_0002876","EFO_1001465","MONDO_0007254","EFO_0000284","EFO_0004252","MONDO_0002877","MONDO_0020654","MONDO_0001056","MONDO_0021043","MONDO_0002158","MONDO_0022394","EFO_0003968","EFO_0003100","EFO_0000183","EFO_0000707","EFO_0000616","EFO_0003897","EFO_0005088","EFO_0006859","EFO_0000186","EFO_0002916","Orphanet_59305","EFO_1000435","EFO_0001645","Orphanet_44890","EFO_0007483","MONDO_0007576","EFO_0007535","EFO_1001953","EFO_0003843","MONDO_0021657","EFO_1001961","EFO_1001471","EFO_0000304","MONDO_0002120","EFO_0002517","MONDO_0011962","EFO_0000764","EFO_0000702","MONDO_0002367","MONDO_0024880","EFO_1001927","EFO_0000519","EFO_0004265","MONDO_0044926","EFO_0005232","MONDO_0003060","EFO_0003869","EFO_0001075","EFO_0004281","EFO_1001958","EFO_0000571","MONDO_0000956","EFO_1000657","MONDO_0004222","EFO_0000228","EFO_1000240","EFO_0000565","EFO_0006462","EFO_0000389","EFO_1001331","EFO_0000182","MONDO_0005411","MONDO_0004321","MONDO_0003000","MONDO_0021115","EFO_0001416","Orphanet_145","EFO_0003893","MONDO_0004658","EFO_0000466","MONDO_0002108","EFO_0004224","MONDO_0008170","MONDO_0004669","EFO_0006772","EFO_0009708","EFO_0000294","EFO_1000576","EFO_0001061","MONDO_0044787","EFO_0003868","EFO_1001100","EFO_1000238","EFO_0005537","EFO_0000233","EFO_1000358","EFO_1000252","EFO_0006544","EFO_1000613","EFO_0000563","MONDO_0021355","EFO_0003785","EFO_1000172","EFO_0002938","MONDO_0015686","MONDO_0004192","EFO_1000236","EFO_0004230","EFO_0000708","MONDO_0002087","MONDO_0024879","EFO_0000305","MONDO_0020657","EFO_1000357","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000043","EFO_0003860","EFO_0006352","EFO_0000673","EFO_1000242","EFO_0004272","EFO_1001963","EFO_1000042","EFO_0002617","EFO_1000158","EFO_0002914","EFO_1000253","MONDO_0001402","EFO_0000685","EFO_1000616","EFO_0006318","EFO_0000503","EFO_0003875","EFO_0000478","EFO_0000556","EFO_0000313","EFO_0003060","EFO_0000311","EFO_1001153","EFO_0003863","EFO_1000581","EFO_0010282","EFO_0006861","EFO_0000095","EFO_0004142","MONDO_0003219","EFO_1000081","EFO_0000612","EFO_0004149","EFO_0003050","EFO_0000691","EFO_0000181","MONDO_0001325","EFO_1000494","EFO_1000233"],"count":202},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 6 approved and 130 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297253","canonicalSmiles":"COc1nc(C(Cl)(Cl)Cl)c(Cl)c(OC(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@@H]4[C@@H]3CC[C@@]3(C)[C@H]4CC[C@@H]3[C@H](C)CCCC(C)C)C2)c1Cl","inchiKey":"ZJUUIXYKTPSIOH-LEZJFEBPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-DEMETHYL-4-CHOLESTERYLOXYCARBONYLPENCLOMEDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-demethyl-4-cholesteryloxycarbonylpenclomedine","Dm-choc-pen"],"crossReferences":{"drugbank":["DB15075"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297285","drugType":"Small molecule","blackBoxWarning":false,"name":"HEME ARGINATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Haem arginate","Heme arginate"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297306","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C","inchiKey":"PHEWVCZHSBTZFX-DBCSJUPNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"NBI-6024","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nbi-6024"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297407","canonicalSmiles":"COC(=O)[C@H]1[C@@H](c2ccc(F)cc2)C[C@@H]2CC[C@H]1N2C/C=C/[123I]","inchiKey":"GTQLIPQFXVKRKJ-HYRAKNMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTROPANE I-123","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4301492","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Altropane i-123","Iacft 123i-labeled form","NAV-5001","NAV-5001 I-123","NAV5001","Nav5001"],"crossReferences":{"drugbank":["DB15144"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297439","canonicalSmiles":"COCN1C(=O)N(COC)C(=O)C(c2ccccc2)(c2ccccc2)C1=O","inchiKey":"RRFBTKHQZRCRSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"T-2000","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T-2000","T2000"],"crossReferences":{"drugbank":["DB11654"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297477","canonicalSmiles":"Cn1cc(Nc2nccc(N3C[C@@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1","inchiKey":"BUWBRTXGQRBBHG-MJBXVCDLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BREPOCITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brepocitinib","PF-06700841","Pf-06700841"],"crossReferences":{"drugbank":["DB15003"]},"childChemblIds":["CHEMBL4298160"],"count":9,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL4297575","drugType":"Antibody","blackBoxWarning":false,"name":"NIRSEVIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MED-18897","MEDI8897","Medi8897","Nirsevimab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297873","drugType":"Unknown","blackBoxWarning":false,"name":"ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Advate","Antihemophilic factor, human recombinant","BAY 14-2222","BAY 81-8973","BAY W 6240","BAY-14-2222","BAY-81-8973","BAY-W-6240","BAY81-8973","Bay81-8973","Factor viii octocog alfa","Factor viii, recombinant","Octocog alfa"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298062","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VILTOLARSEN","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Viltepso"],"synonyms":["NCNP-01","NS-065","NS-065/NCNP-01","Ns-065/ncnp-01","Viltolarsen"],"count":1,"approvedIndications":["Orphanet_98896"],"linkedTargets":{"rows":["ENSG00000198947"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for duchenne muscular dystrophy."}
{"id":"CHEMBL4298075","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPOLIS WAX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Propolis","Propolis wax"],"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4303510","canonicalSmiles":"Cl.Cl.NCCc1cc[nH]n1","inchiKey":"BUXCUOWXTOKEMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303510","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201323","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL435191","canonicalSmiles":"O=C1c2c(c3c4ccc(O)cc4n([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c3[nH]c4cc(O)ccc4c23)C(=O)N1NC(CO)CO","inchiKey":"QMVPQBFHUJZJCS-NTKFZFFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDOTECARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edotecarin","J-107088","PF-804950"],"crossReferences":{"drugbank":["DB04882"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL440498","canonicalSmiles":"O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1","inchiKey":"ROSNVSQTEGHUKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CTS-1027","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cts-1027","RO-1130830","RS-130830"],"crossReferences":{"drugbank":["DB08490"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4435170","canonicalSmiles":"[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC","inchiKey":"BZZKEPGENYLQSC-FIBGUPNXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEUCRAVACITINIB","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4596392","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986165","Bms-986165","Deucravacitinib"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL444144","canonicalSmiles":"COCCO","inchiKey":"XNWFRZJHXBZDAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-METHOXYETHANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Methoxyethanol"],"crossReferences":{"PubChem":["144211397","68096"],"Wikipedia":["2-Methoxyethanol"],"drugbank":["DB02806"],"chEBI":["46790"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL448500","canonicalSmiles":"OCCc1ccccc1","inchiKey":"WRMNZCZEMHIOCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLETHYL ALCOHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenethanol","Phenethyl alcohol","Phenylethanol","Phenylethyl alcohol"],"crossReferences":{"PubChem":["144207093","144208520","144213695","170466787","29217973","47193693"],"Wikipedia":["Phenethyl_alcohol"],"drugbank":["DB02192"],"chEBI":["49000"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594248","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(N)=O)C(C)C","inchiKey":"LDVRMNJZLWXJPL-JKQNMTHDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CALCITONIN HUMAN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cibacalcin"],"synonyms":["Calcitonin (human synthetic)","Calcitonin human"],"count":1,"approvedIndications":["EFO_0005754"],"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["EFO_0005754"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1986 and is indicated for parathyroid disease."}
{"id":"CHEMBL4594394","canonicalSmiles":"O=C([O-])CCCO.O=C([O-])CCCO.[Mg+2]","inchiKey":"QWZIZKOBUUSCLO-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM OXYBATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1342","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Magnesium oxybate"],"crossReferences":{"DailyMed":["magnesium%20oxybate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020."}
{"id":"CHEMBL4594436","canonicalSmiles":"Cc1cc([N+](=O)[O-])c(NS(=O)(=O)c2cccc(C(=O)O)c2)cc1-c1cccnc1","inchiKey":"QUQGQIASFYWKAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOFANIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alofanib"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594477","drugType":"Unknown","blackBoxWarning":false,"name":"IMA-026","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ima-026"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594547","drugType":"Antibody","blackBoxWarning":false,"name":"TEMELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNBAC1","Gnbac1","Temelimab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594611","drugType":"Antibody","blackBoxWarning":false,"name":"PATRITUMAB DERUXTECAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Patritumab deruxtecan","U3 1402","U3-1402","U3-1402A"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL486819","canonicalSmiles":"CC(=O)O.CC(=O)O.NC(=N\\CCCCCC/N=C(N)/N=C(\\N)Nc1ccc(Cl)cc1)/N=C(\\N)Nc1ccc(Cl)cc1","inchiKey":"WDRFFJWBUDTUCA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORHEXIDINE DIACETATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL790","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorhexidine acetate","Chlorhexidine diacetate","NSC-526936"],"crossReferences":{"PubChem":["144212680","26752882"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL494753","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O","inchiKey":"JKKFKPJIXZFSSB-CBZIJGRNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRONE SULFURIC ACID","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Estrone Sulphate"],"crossReferences":{"DailyMed":["estropipate"],"PubChem":["11112590"],"Wikipedia":["Estrone_sulfate"],"drugbank":["DB04574"],"chEBI":["17474"]},"childChemblIds":["CHEMBL1200980","CHEMBL1546237","CHEMBL2106240"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977. This drug has a black box warning from the FDA."}
{"id":"CHEMBL499808","canonicalSmiles":"CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O","inchiKey":"JYIKNQVWKBUSNH-OGZDCFRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASPOFUNGIN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cancidas"],"synonyms":["Caspofungin","Caspofungin acetate","L-743,872","L-743872","MK-991"],"crossReferences":{"DailyMed":["caspofungin%20acetate"],"Wikipedia":["Caspofungin"],"chEBI":["474180"]},"childChemblIds":["CHEMBL4297142"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 8 investigational indications."}
{"id":"CHEMBL535165","canonicalSmiles":"CCCn1c(=O)c2nc(C34CCC(CCC(=O)O)(CC3)CC4)[nH]c2n(CCC)c1=O.Cl","inchiKey":"ASCKWGGGWHSGAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL535165","maximumClinicalTrialPhase":0,"parentId":"CHEMBL414157","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54893","canonicalSmiles":"CC(C)=CCOc1cc(NC(=S)c2ccoc2C)ccc1Cl","inchiKey":"YZHIXLCGPOTQNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UC 781","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["UC-781","Uc 781"],"crossReferences":{"PubChem":["515904"],"drugbank":["DB05871"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL556","canonicalSmiles":"CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN","inchiKey":"UBQYURCVBFRUQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFEROXAMINE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Deferoxamine","Desferal","Desferrioxamine","NSC-527604"],"crossReferences":{"DailyMed":["deferoxamine%20mesylate"],"PubChem":["93577020"],"Wikipedia":["Deferoxamine"],"drugbank":["DB00746"],"chEBI":["4356"]},"childChemblIds":["CHEMBL2002581","CHEMBL1234"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 7 investigational indications."}
{"id":"CHEMBL572879","canonicalSmiles":"Nc1ccc(N)c2c1C(=O)c1c(O)ccc(O)c1C2=O","inchiKey":"QVEMRPAUHFWHRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL572879","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03924"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL588912","canonicalSmiles":"CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"FFUCUNIBSOIVIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOGUANIL PAMOATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL747","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCMDC-125837"],"crossReferences":{"PubChem":["118494"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL610","canonicalSmiles":"NCCc1ccccc1","inchiKey":"BHHGXPLMPWCGHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENETHYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenethylamine","Phenylethylamine"],"crossReferences":{"PubChem":["26756723","49718670"],"Wikipedia":["Phenethylamine"],"drugbank":["DB04325"],"chEBI":["18397"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL62836","canonicalSmiles":"CC(C)COc1cccc(-c2nc3cc(C(=N)N)c(F)cc3[nH]2)c1O","inchiKey":"NSUDDASMRZSVON-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL62836","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06855"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL634","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1","inchiKey":"IDBPHNDTYPBSNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALFENTANIL","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alfentanil","IDS-NA-014","R-39209","R-39209-"],"crossReferences":{"Wikipedia":["Alfentanil"],"drugbank":["DB00802"],"chEBI":["2569"]},"childChemblIds":["CHEMBL1200531"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0004799","EFO_0010282","EFO_0009447","MONDO_0008903","EFO_0003843","HP_0000713"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986. This drug has a black box warning from the FDA."}
{"id":"CHEMBL64894","canonicalSmiles":"CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]","inchiKey":"ZXJXZNDDNMQXFV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"GENTIAN VIOLET","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL459265","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["GV 11","Genapax","Methylrosaniline Cl","Methylrosanilinium Cl","Pyoktanin","Viocid"],"synonyms":["Crystal violet","GNF-Pf-880","Gentian violet","Methyl violet","Methylrosaniline chloride","Methylrosanilinium chloride","NSC-3090"],"crossReferences":{"PubChem":["144204635","144208960","144210888","170464787","17389869","26748060","26752909","538591"],"Wikipedia":["Crystal_violet","Methyl_violet"],"chEBI":["41688"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 2 investigational indications."}
{"id":"CHEMBL74074","canonicalSmiles":"O=P(O)(O)OCCCc1c[nH]c2ccccc12","inchiKey":"NKEZSFZOUIIZFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL74074","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03171"],"chEBI":["28162"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL80830","canonicalSmiles":"CC(C)(S)C(=O)N[C@@H](CS)C(=O)O","inchiKey":"VUAFHZCUKUDDBC-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCILLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bucillamine"],"crossReferences":{"PubChem":["144206698"],"Wikipedia":["Bucillamine"],"drugbank":["DB12160"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL896","canonicalSmiles":"OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"ZQDWXGKKHFNSQK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYZINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Atarax","Hydroxyzine","NSC-169188","Orgatrax"],"crossReferences":{"DailyMed":["hydroxyzine%20hydrochloride","hydroxyzine%20pamoate"],"PubChem":["144207118","170464958"],"TG-GATEs":["71"],"Wikipedia":["Hydroxyzine"],"drugbank":["DB00557"],"chEBI":["5818"]},"childChemblIds":["CHEMBL1201007","CHEMBL3186993","CHEMBL1200467"],"count":4,"approvedIndications":["EFO_0005230"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","HP_0000989","MONDO_0002050","EFO_0003819","HP_0000726","EFO_0000701","EFO_0004257","EFO_0005230","EFO_0003843","EFO_0000692"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and is indicated for anxiety and has 3 investigational indications."}
{"id":"CHEMBL927","canonicalSmiles":"C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\\O)c3csc(N)n3)[C@H]2SC1","inchiKey":"RTXOFQZKPXMALH-GHXIOONMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFDINIR","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefdinir","Cefzon","Omnicef"],"synonyms":["BMY-28488","CI-983","Cefdinir","FK 482","FK-482"],"crossReferences":{"DailyMed":["cefdinir"],"PubChem":["56422579"],"Wikipedia":["Cefdinir"],"drugbank":["DB00535"],"chEBI":["3485"]},"count":9,"approvedIndications":["EFO_0003106","EFO_0000771","EFO_0000544","EFO_0004992","EFO_0006505","HP_0011110","MONDO_0002258"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 7 approved and 2 investigational indications."}
{"id":"CHEMBL98123","canonicalSmiles":"COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC.Cl","inchiKey":"UOTMYNBWXDUBNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAPAVERINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL19224","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Papaver hcl","Pavabid"],"synonyms":["NSC-35443","Papaverine hydrochloride"],"crossReferences":{"PubChem":["144203777","170465687","26747626","50106832","544606","56422444","855961"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL998","canonicalSmiles":"CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1","inchiKey":"JCCNYMKQOSZNPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORATADINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alavert","Children's claritin","Claritin","Claritin hives relief","Claritin hives relief reditab","Claritin reditabs","Clarityn","Clarityn rapide","Clarityne","Hay-rite","Loratadine","Loratadine redidose","Roletra"],"synonyms":["BAY76-2211","Claritin-D","Loratadine","SCH 29851","SCH-29851"],"crossReferences":{"DailyMed":["loratadine"],"PubChem":["104171183","11111394","11113345","124880597","124880599","144203736","144211849","170464867","26719690","26747010","26751528","50104102","535878","56424146","85231118","855843","90340694"],"Wikipedia":["Loratadine"],"drugbank":["DB00455"]},"childChemblIds":["CHEMBL4092143"],"count":14,"approvedIndications":["EFO_0005854","EFO_0003785","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0008521","EFO_0000685","MONDO_0007254","HP_0003418","EFO_0000274","EFO_0004232","EFO_0003885","EFO_0005531","HP_0002653","EFO_0000270","EFO_0000574","EFO_0001378","EFO_1001417","EFO_0003956","EFO_0003785"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 3 approved and 11 investigational indications."}
